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Introduction
The introduction of antiretroviral treatment (ART) for HIV infection has significantly reduced the morbidity and mortality of HIV infected individuals [1] . However, the success of treatment depends on the disease progression at HIV diagnosis and adequate initiation of ART [2, 3] . Low CD4 cell count at HIV diagnosis termed late presentation (LP) and late presentation with advanced disease (AD) have been associated with higher mortality [4] , higher cost of medical management [5] , impaired CD4 cell count increment [6, 7] and potentially ongoing risk of HIV transmission [8, 9] . Furthermore, lag time between CD4 cell count measurement and subsequent medical consultation where ART initiation is decided, may contribute to further disease progression and loss to follow-up [10, 11] . Thus, intensified efforts are needed to identify and enroll HIV infected individuals earlier into care [12] . In West Africa, two types of HIV are circulating: HIV-1 and HIV-2. The UNAIDS estimates that in this part of the world less than half of the HIV infected individuals in need of ART are actually receiving the treatment [1] . The West African country Guinea-Bissau has the world´s highest prevalence of HIV-2 and the prevalence of HIV-1 has been rising [13] . Compared with HIV-1, HIV-2 is less transmissible, associated with a lower viral load and with a slower rate of both CD4 cell decline and clinical progression. Still, it may lead to AIDS, with clinical features indistinguishable from the syndrome caused by HIV-1 [14] [15] [16] . In this study, we describe the proportion of HIV-1 and/or HIV-2 infected patients with LP and AD at an HIV clinic in Bissau, to identify risk factors thereof and to evaluate the outcome of these patients.
Methods

Setting and patients
In June 2005, the first HIV clinic opened in Bissau, the capital of Guinea-Bissau, providing ART free-of-charge, and the clinic is now the largest ART center in the country in terms of patients on followup. CD4 cell count measurements have been performed since 2007, and the same year the Bissau HIV Cohort was established to evaluate patient treatment and follow-up [17] . Routines at the clinic has previously been described [18] . In this retrospective cohort study, patients >15 years were enrolled at the HIV clinic at Hospital National Simão Mendes (HNSM) in Bissau, Guinea-Bissau in the 
Definition of LP and AD
Based on a consensus definition [17] we defined LP as patients presenting for care with a CD4 cell count below 350 cells/µL. AD were defined as patients presenting with a CD4 cell count below 200 cells/µL or presenting with an AIDS-defining event, regardless of the CD4 cell count. Only patients with a CD4 cell count measured within 90 days of HIV diagnosis were included in the analyses.
Statistical methods
We compared the demographic, clinical and laboratory features of patients with AD, LP and non-LP using χ 2 test for categorical 
Results
General characteristics
A total of 5,562 patients were diagnosed with HIV in the study period, but 68 (1.2%) patients were excluded as they were already receiving ART at first CD4 cell count. 
Description of CD4 cell counts
The median time between HIV diagnosis and initial CD4 cell count 
Risk factors of LP and AD
Risk factors of AD in the multivariable analysis (Table 2) 
Initiation of ART
ART was initiated among 2,395 (64.4%) patients during the study period, and this proportion was higher among patients with LP patients initiated ART the same day as they were diagnosed with HIV.
Mortality of patients
All patients were included in the mortality analysis and contributed with 6,950 person-years of observation. During follow-up, 532 deaths were registered; overall mortality rate (MR) = 7.7 (95% CI: 
Patients lost to follow-up and patients transferred
According to our definition, 2,169 (58.3%) patients became lost to follow-up during the study period. The proportion of patients lost to follow-up was higher among non-late presenters (67.8%) and patients with LP (60.5%) compared with AD (51.8%, p < 0.001). In total, 178 (4.8%) patients were transferred to another facility with no difference between groups; non-LP (4.5%), LP (5.9%) and AD (4.4%, p=0.19). By the end of the study period 841 (22.6%) of the patients were alive on follow-up.
Discussion
In this cohort, 65.7% of the HIV infected patients had a CD4 cell count measured within the first 90 days of the HIV diagnosis.
Almost half the patients presented with AD and additionally one quarter were late presenters. Risk factors of AD were male sex, age cohorts are characterized by a high rate of loss to follow-up [10, 19] and in a meta-analysis a combined 40% of patient lost to follow-up had in fact died. Thus loss to follow-up in our study may have underestimated the true mortality rate [20] . Another limitation is the uncertainty in the HIV typing. We have previously shown that the rapid test used in Guinea-Bissau for HIV type discrimination (SD Bioline HIV 1/2 3.0) may overestimate the number of HIV-1/2 dually infected patients [21, 22] [28] . The numerous risk factors of LP/AD mentioned above indicates the diversity in explanatory causes of late HIV testing and demonstrates the need for local studies. Causes of LP/AD may differ with geographical region and local settings. As in our study, male sex was a risk factor of LP in many of these African studies possibly reflecting a poorer health-seeking behavior in the male population [12, [26] [27] [28] [29] . In Bissau male sex is also associated with higher rates of loss to follow-up after CD4 cell count measurement [10] .
Implications
Among all patients diagnosed with HIV at our clinic, 33.1% did not days [31] . However, the performance of different point-of-care devices for CD4 cell count varies with regard to accuracy and costs [32] . The implementation of point-of-care monitoring tools at decentralized clinic laboratories may therefore be warranted [33] .
HIV-2 infected patients presented with higher CD4 cell counts in our Controversially, studies have suggested that initial infection with HIV-2 may protect against subsequent HIV-1 disease progression [34, 35] whereas other studies did not find a protective effect [36] .
Based on the HIV tests used, we found that HIV-1/2 dually infected were associated with AD in this study, constitutes two major population group in West Africa. In Guinea-Bissau distinct living conditions and cultural patterns are practiced in these ethnic groups, participation in vaccination campaigns are lower and child mortality is higher than in other groups [38] [39] [40] [41] . Similarly, the mortality rate was higher in these ethnic groups among women of reproductive age [42] . HIV-1 infection was also associated with Mandinga ethnicity in a study among pregnant women in Bissau [43] . Association between AD and Fula/Mandinga ethnicity may reflect differences in geographic origin [42] , socioeconomic characteristics and health seeking behavior [40] . During the study for patients with AD, but may be improved with rapid initiation of ART. We have previously described that loss to follow-up bears a significant cause of the failure to start ART both before and after the first CD4 cell count [10] .
Unanswered questions for future research
As patients with AD have higher mortality rates, it should be of high 
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